Market Cap 6.55B
Revenue (ttm) 508.82M
Net Income (ttm) -67.09M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -13.19%
Debt to Equity Ratio 1.13
Volume 8,924,000
Avg Vol 1,879,420
Day's Range N/A - N/A
Shares Out 64.58M
Stochastic %K 99%
Beta 0.83
Analysts Strong Sell
Price Target $127.31

Latest News on BPMC

Sanofi-Blueprint deal is a bullish signal about biotech M&A

Jun 2, 2025, 11:46 AM EDT - 2 days ago

Sanofi-Blueprint deal is a bullish signal about biotech M&A

SNY


Sanofi buys US biopharma group Blueprint in $9.1 bln deal

Jun 2, 2025, 1:24 AM EDT - 3 days ago

Sanofi buys US biopharma group Blueprint in $9.1 bln deal

SNY


Blueprint Medicines to Present at Upcoming Investor Conferences

Sep 10, 2024, 8:00 AM EDT - 9 months ago

Blueprint Medicines to Present at Upcoming Investor Conferences